Biotech Intellia Therapeutics to Present Interim Clinical Data from Ongoing Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema at the 2022 Bradykinin Symposium August 24, 2022
Biotech Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion August 24, 2022
Biotech Travere Therapeutics and CSL Vifor Announce EMA has Accepted for Review the Conditional Marketing Authorization Application for Sparsentan for the Treatment of IgA Nephropathy August 23, 2022
Biotech Arcutis Announces Arcutis Cares(TM) Patient Assistance Program (PAP) For Financially Qualified Uninsured and Underinsured Patients August 23, 2022
Biotech Veru Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin Treatment in Hospitalized COVID-19 Patients by Australia’s Therapeutic Goods Administration August 23, 2022
Biotech REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium August 23, 2022
Biotech Arcutis Completes Enrollment in INTEGUMENT-2 Pivotal Phase 3 Trial of Ro?umilast Cream in Atopic Dermatitis August 23, 2022
Search
Biotech
August 24, 2022
August 24, 2022
August 24, 2022
August 24, 2022
August 24, 2022
August 23, 2022
August 23, 2022
August 23, 2022
August 23, 2022
August 23, 2022
